Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway
AMB Express volume 10, Article number: 165 (2020)
We explored how tabersonine (Tab) protected against dexamethasone (Dex)-induced osteoporosis. Osteoblasts were treated with Dex (100 µM) with or without Table (5 or 10 µM). We measured cell viability, alkaline phosphatase (ALP) activity, and mitochondrial superoxide and reactive oxygen species levels. We used flow cytometry to explore the effects of Tab on mitochondrial membrane potential and osteoblast apoptosis. We used RT-PCR and western blotting to examine the effect of Tab on protein expression. We evaluated the effects of Tab on bone histopathology and bone mineral density in rats with Dex-induced osteoporosis. Tab increased cell viability and ALP activity, and reduced the mitochondrial superoxide, reactive oxygen species and matrix metalloproteinase levels and osteoblast apoptosis. Tab significantly reduced the levels of nuclear factor erythroid 2-related factor 2 (Nrf2), haem oxygenase-1 and NAD(P)H quinone dehydrogenase 1. Moreover, it increased the levels of mRNAs encoding runt-related transcription factor 2, bone morphogenetic protein-2 and osterix. These data suggest that Tab ameliorates Dex-induced osteoporosis by regulating the Nrf2 signalling pathway.
Osteoporosis is a metabolic bone disease characterised by the loss of bone mass and bone weakness; it affects about 200 million individuals (80% of whom are female) worldwide (Sözen et al. 2017). Skeletal integrity is compromised in osteoporotic patients; an imbalance develops between bone formation and resorption, triggering fracture (Office of the Surgeon General (USA) 2004). Osteoblasts are responsible for bone formation and mineralisation. Several factors regulate osteoblast activity. Oestrogen enhances osteoblastic mineralisation and stimulates osteoblast differentiation and proliferation (Domazetovic et al. 2017). In females, osteoporosis commonly develops after menopause or ovariectomy (Luo et al. 2014). Nuclear factor erythroid 2-related factor 2 (Nrf2) expression contributes to osteoporosis development by enhancing reactive oxygen species (ROS) production (Ma et al. 2013). Mitochondrial dysfunction enhances osteocyte apoptosis, reducing bone mineralisation via ROS overproduction (Smietana et al. 2010). The antioxidant responsive element, in combination with the Nrf2 activator, prevents osteoporosis development by enhancing the expression levels of antioxidant enzymes (Jin et al. 2020). Osteoblast activity is regulated by the Nrf2 pathway (Sun et al. 2015). Conventional osteoporosis treatments have several limitations; alternative medicines have shown promise over the past few decades.
Tabersonine (Tab), originally isolated from Catharanthus roseus (Apocynaceae), is a terpene indole alkaloid found in several medicinal plants (Almagro et al. 2015). C. roseus is traditionally used in China for the management of cancer, malaria and diabetes (Nejat et al. 2015). Tab has strong anticancer and neuroprotective effects (Nejat et al. 2015). It protects against lung injury by regulating the NF-κB and p38/MK2 pathways, thereby strongly inhibiting inflammation (Zhang et al. 2018). In this study, we explored whether Tab protected against dexamethasone (Dex)-induced osteoporosis, and the molecular mechanism in play.
Materials and methods
Neonatal Sprague-Dawley rats (strain P2) were sacrificed via decapitation and their calvaria were isolated for in vitro analysis. The in vivo study was performed with 8-week-old female rats (mean body weight 250 ± 25 g), held under standard laboratory conditions. All animal procedures were approved by the animal ethics committee of the First Hospital of Jilin University, China (Approval no. IAEC/FH-JU/2018/01).
Tab was supplied by the Institute of Botany, Chinese Academy of Sciences, China; Dex was obtained from Tianjin Lisheng Pharmaceutical Co. Ltd., China. Alkaline phosphatase (ALP), Nrf2, and matrix metalloproteinase detection kits were purchased from Abcam, USA. The antibodies used for western blotting and the qRT-PCR primers were obtained from Thermo Fisher Scientific, USA.
Osteoblast isolation and culture
Calvarial osteoblasts were isolated from neonatal rats as described previously (Liu et al. 2019). The connective tissue was cleaned carefully and digested with 0.3% (w/v) type II collagenase after isolation of the parietal bones. The cells were cultured in DMEM supplemented with antibiotics and antimycotics, charcoal dextran-treated foetal blood serum and non-essential amino acids (100 µM) for 48 h.
Estimation of cell viability
Cell proliferation was estimated using the CCK-8 assay as described previously (Jo et al. 2015). Cells (2 × 104/well) were seeded into six-well plates, incubated for 24 h, treated with 100 µM Dex with or without the addition of Table (5 or 10 µM) 2 h previously, and cultured for 24 h; CCK-8 was then added, followed by incubation for 2 h. Cell viability was determined by estimating absorbance at 450 nm using a microplate reader.
Measurement of ALP activity
Osteoblasts (2 × 105 cells/well) were seeded into six-well plates and treated with Dex with or without Tab for various durations. The cells were lysed with lysis buffer, and ALP levels were measured as directed by the kit manufacturer.
Mitochondrial superoxide and ROS assays
Flow cytometry was used to measure mitochondrial superoxide and ROS levels in osteoblasts, with the use of the MitoSOXTM Red indicator and a nonfluorescent 2,7-dichlorofluorescin diacetate probe, respectively.
The TransAM Nrf2 assay was used to estimate Nrf2 activity, according to the manufacturer’s instructions. An ELX800 microplate reader was employed to measure absorbance at 405 nm.
Mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was estimated using the lipophilic, cationic fluorescent dye 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazol-carbocyanine iodide. Osteoblasts (2 × 105 cells/well) were seeded into six-well plates and the Mitochondrial Membrane Potential Detection Kit was used to estimate MMP according to the manufacturer’s instructions.
Osteoblasts (2 × 105 cells/well) were seeded into six-well plates and treated with Dex with or without Tab for various durations. The cells were resuspended in 500 µl binding buffer containing PI (5 µl) and Annexin V-APC (5 µl), rinsed with PBS, and placed on ice. Flow cytometry was used to measure apoptosis.
Osteoblasts were cultured with Tab for 48 h. Total RNA was extracted using the TRIZOL reagent and cDNA was synthesised using SuperScript II reverse transcriptase. qRT-PCR was performed using the SYBR Green PCR Master Mix system. GAPDH served as the internal control. Cycle number (the Cq value) was plotted against the log of the added cDNA concentration, and relative target gene expression levels were determined using the 2−ΔΔCq method.
Total osteoblast proteins were extracted into ice-cold radioimmunoprecipitation lysis buffer, and the DC Protein Assay was performed to estimate protein levels. Sodium dodecyl sulphate-polyacrylamide gel (10% w/v) electrophoresis was used to separate the proteins, which were then transferred to polyvinylidene difluoride membranes. The membranes were incubated with a 5% (w/v) fresh nonfat dry milk solution to block non-specific reactions. They were incubated at 4 ºC overnight with primary antibodies against Nrf2 (1:500), Ho-1 (1:1000), NAD(P)H quinone dehydrogenase 1 (NQO-1; 1:1000), caspase-3 (1:500), Bcl-2 (1:1000), Bax (1:1000), cytochrome-C (1:200) and β-actin (1:1000), and then at room temperature for 60 min with appropriate secondary antibodies. The enhanced chemiluminescence assay was used to detect protein bands, and the ImageLab software was employed for densitometric analysis.
Rats were separated into four groups: control, Dex (1 mg/kg intramuscularly, daily for 60 days), and Tables 20 and 40 (20 and 40 mg/kg intraperitoneally, 30 min after Dex administration for 60 days). The animals were then sacrificed, and the bilateral femora were collected.
Determination of bone mineral density
Dual energy X-ray absorptiometry was used to determine the bone mineral density (BMD). Rats were anesthetised with Zoletil/Rompun, and the femora, lumbar vertebrae and whole body were scanned for the evaluation of BMD.
The isolated tibiae were fixed in 10% (v/v) formalin at 40 °C for 2 days. Ethylenediaminetetraacetic acid (10% v/v) was used to decalcify the bones, which were then placed in liquid paraffin to create wax blocks. Sections (4 µm thickness) were prepared and stained with haematoxylin and eosin. Histopathological changes were identified under a tri-ocular microscope at 100× magnification.
All data are expressed as means ± standard errors of the means (n = 10/group). One-way analysis of variance, followed by the Dunnett test, was performed using the GraphPad Prism software (ver. 6.1; GraphPad Software Inc., USA). p values < 0.05 were considered to reflect statistical significance.
Effect of Tab on osteoclast viability
Dex reduced osteoblast viability (compared with the control) and Tab rescued viability, as revealed by the CCK-8 assay (Fig. 1).
Effect of Tab on ALP activity
Dex significantly reduced the osteoblast ALP level compared with the control (p < 0.01; Fig. 2), and Tab neutralised this negative effect of Dex.
Effects of Tab on mitochondrial superoxide and ROS levels
The effects of Tab on mitochondrial superoxide and ROS levels, as determined by flow cytometry, are shown in Fig. 3. Dex enhanced the production of mitochondrial superoxide and ROS compared with the control. Tab neutralised these negative effects of Dex.
Effect of Tab on the MMP
The MMP was measured by estimating mitochondrial depolarisation via the change in the red/green fluorescence ratio (Fig. 4). The MMP was lesser in Dex-treated osteoblasts than in controls, and Tab neutralised this negative effect.
Effect of Tab on osteoblast apoptosis
Osteoblast apoptosis was measured via flow cytometry (Fig. 5). Apoptosis was greater in Dex-treated than in control osteoblasts, and Tab neutralised this negative effect of Dex.
Effects of Tab on the levels of mRNAs encoding runt-related transcription factor 2, bone morphogenetic protein-2 and osterix
The levels of mRNAs encoding runt-related transcription factor 2 (RUNX2), bone morphogenetic protein-2 (BMP-2) and osterix were measured in osteoblasts treated with Dex alone or Dex and Tab (Fig. 6). The mRNA levels decreased upon Dex treatment, and Tab neutralised these negative Dex effects.
Effect of Tab on Nrf2 signalling
The effect of Tab on Nrf2 signalling was evaluated by measuring the levels of Nrf2, Ho-1 and NQO-1 in osteoblasts via western blotting; Nrf2 activity was also determined using the TransAM Nrf2 kit (Fig. 7a, b). The Nrf2, Ho-1 and NQO-1 levels were lower in Dex-treated than in control osteoblasts. Tab significantly neutralised the negative effects of Dex (Fig. 7a). Nrf2 activity was reduced in Dex-treated cells compared with control cells. Again, Tab neutralised this negative effect of Dex (Fig. 7b).
Effects of Tab on the expression of caspase-3, Bcl-2, Bax and cytochrome-C
Tab affected the levels of pre- and pro-apoptotic proteins in Dex-treated osteoblasts (Fig. 8). Dex significantly increased the levels of caspase-3, Bax and cytochrome-c and reduced that of Bcl-2 compared with controls. Tab neutralised these adverse effects of Dex.
Effects of Tab on bone histopathology and BMD
Tab affected bone histopathology and BMD in rats with Dex-induced osteoporosis (Fig. 9). The control group exhibited normal bone. Dex destroyed bone trabeculae (as revealed by staining) and reduced bone synthesis. Tab neutralised these negative effects. The BMD was significantly lower in the Dex group than in the control group; Tab largely neutralised this deterioration.
Bone homeostasis is affected by osteoporosis, a disease characterised by the dysregulation of bone formation and resorption. Osteoblasts regulate bone formation and osteoclasts control bone resorption (Feng and McDonald 2011). Dex compromises osteoblast function; Dex-induced models of osteoporosis are used widely for the pharmacological evaluation of potentially useful anti-osteoporosis drugs (Yin et al. 2019). We employed a Dex-induced osteoporosis model to explore the effects of Tab on osteoblast viability, ALP activity, mitochondrial superoxide and ROS production, the MMP and apoptosis (the latter two parameters were assessed by flow cytometry). We performed RT-PCR and western blotting to explore the effects of Tab on osteoblast protein expression.
Mitochondria play important roles in cell survival and apoptosis (Wang and Youle 2009). Dex affects mitochondrial respiration by inducing ROS synthesis, in turn activating the cytochrome-C-associated pro-apoptotic pathway and the caspase cascade (Liu et al. 2018). Tab treatment enhanced the viability of Dex-treated osteoblasts and ALP activity, and reduced mitochondrial superoxide and ROS production. Tab attenuated the expression of caspase-3, Bcl-2, Bax, and cytochrome-c in Dex-treated osteoblasts. Flow cytometric analysis revealed that Tab enhanced the MMP and reduced apoptosis of Dex-treated osteoblasts.
Nrf2 signalling protects osteoblasts (Sena and Chandel 2012). The mitochondrial ROS level is regulated by Ho-1, NQO-1, and Nrf2 (Li et al. 2014). In models of osteoporosis, the Nrf2 pathway is suppressed, accompanied by mitochondrial dysfunction (Huang et al. 2019). We observed higher levels of Nrf2, Ho-1 and NQO-1 in the Tab groups than in the Dex group. The levels of mRNAs encoding RUNX2, BMP-2 and osterix were significantly enhanced in the Tab-treated groups compared with the Dex-treated group (all p < 0.01). In conclusion, our findings suggest that Tab ameliorates Dex-induced osteoporosis by regulating Nrf2/ROS/Bax signalling. Thus, Tab may be clinically valuable for osteoporosis management.
Availability of data and materials
The supporting data are not available for ethical reasons.
Almagro L, Fernández-Pérez F, Pedreño MA (2015) Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health. Molecules 20(2):2973–3000
Feng X, McDonald JM (2011) Disorders of bone remodeling. Annu Rev Pathol 6:121–145
Huang MLH, Chiang S, Kalinowski DS, Bae DH, Sahni S, Richardson DR (2019) The role of the antioxidant response in mitochondrial dysfunction in degenerative diseases: cross-talk between antioxidant defense, autophagy, and apoptosis. Oxid Med Cell Longev 2019:6392763
Jin W, Zhu X, Yao F, Xu X, Chen X, Luo Z, Zhao D, Li X, Leng X, Sun L (2020) Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2/HO-1 signaling pathway. Biomed Pharmacother 121:109676
Jo HY, Kim Y, Park HW, Moon HE, Bae S, Kim J, Kim DG, Paek SH (2015) The unreliability of MTT assay in the cytotoxic test of primary cultured glioblastoma cells. Exp Neurobiol 24(3):235–245
Li L, Dong H, Song E, Xu X, Liu L, Song Y (2014) Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling. Chem Biol Interact 209:56–67
Liu S, Zhou L, Yang L, Mu S, Fang T, Fu Q (2018) Gastrodin alleviates glucocorticoid induced osteoporosis in rats via activating the Nrf2 signaling pathways. Oncotarget 9(14):11528–11540
Liu B, Lu Y, Wang Y, Ge L, Zhai N, Han J (2019) A protocol for isolation and identification and comparative characterization of primary osteoblasts from mouse and rat calvaria. Cell Tissue Bank 20(2):173–182
Luo K, Ma S, Guo J, Huang Y, Yan F, Xiao Y (2014) Association between postmenopausal osteoporosis and experimental periodontitis. Biomed Res Int. 2014:316134
Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401–426
Nejat N, Valdiani A, Cahill D, Tan YH, Maziah M, Abiri R (2015) Ornamental exterior versus therapeutic interior of Madagascar periwinkle (Catharanthus roseus): the two faces of a versatile herb. Sci World J 2015:982412
Office of the Surgeon General (US) (2004) Bone health and osteoporosis: a report of the surgeon general. 2, The basics of bone in health and disease. Office of the Surgeon General (US), Rockville
Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158–167
Smietana MJ, Arruda EM, Faulkner JA, Brooks SV, Larkin LM (2010) Reactive oxygen species on bone mineral density and mechanics in Cu, Zn superoxide dismutase (Sod1) knockout mice. Biochem Biophys Res Commun 403(1):149–153
Sözen T, Özışık L, Başaran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46–56
Sun YX, Xu AH, Yang Y, Li J (2015) Role of Nrf2 in bone metabolism. J Biomed Sci 22:101
Wang C, Youle RJ (2009) The role of mitochondria in apoptosis. Annu Rev Genet 43:95–118
Yin H, Wang J, Wu M, Ma Y, Wang S, Su Q (2019) Preventive effects of evodiamine on dexamethasone-induced osteoporosis in zebrafish. Biomed Res Int 2019:5859641
Zhang D, Li X, Hu Y, Jiang H, Wu Y, Ding Y, Yu K, He H, Xu J, Sun L, Qian F (2018) Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochem Pharmacol 154:183–192
The authors thank the First Hospital of Jilin University, China, for providing facilities.
No external funding was received.
Ethics approval and consent to participate
The animal experiments were approved by the animal ethics committee of the First Hospital of Jilin University, China (No. IAEC/FH-JU/2018/01).
Consent for publication
No author has any possibly competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sun, X., Gan, L., Li, N. et al. Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway. AMB Expr 10, 165 (2020). https://doi.org/10.1186/s13568-020-01098-0